AFNAS
IONS icon

American Financial Network Advisory Services’s Ionis Pharmaceuticals IONS Stock Holding History

American Financial Network Advisory Services’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-90
Closed -$5K – 374
2017
Q4 		$5K Sell
90
-111
-55% -$6.09K ﹤0.01% 553
2017
Q3 		$10K Buy
+201
New +$10.5K ﹤0.01% 488

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

American Financial Network Advisory Services's IONS Position: Q1 2018 in Review

American Financial Network Advisory Services sold out of Ionis Pharmaceuticals (IONS) in Q1 2018, closing a stake of 90 shares — an estimated $5K sold.

American Financial Network Advisory Services first reported a position in IONS in Q3 2017 and held it in 2 quarters. The position peaked at $10K in Q3 2017. 326 funds tracked by Wall St. Rank hold IONS as of Q1 2018.

  • American Financial Network Advisory Services reported no remaining Ionis Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • American Financial Network Advisory Services sold 90 Ionis Pharmaceuticals shares in Q1 2018, an estimated $5K.
  • American Financial Network Advisory Services first reported a position in Ionis Pharmaceuticals in Q3 2017 and held it in 2 quarters.
  • American Financial Network Advisory Services's Ionis Pharmaceuticals position peaked at $10K in Q3 2017.
  • 326 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2018.

Based on American Financial Network Advisory Services's 13F filing for Q1 2018, filed 15 May 2018.